Author: David E. Gordon; Gwendolyn M. Jang; Mehdi Bouhaddou; Jiewei Xu; Kirsten Obernier; Matthew J O'Meara; Jeffrey Z. Guo; Danielle L. Swaney; Tia A. Tummino; Ruth Huttenhain; Robyn Kaake; Alicia L. Richards; Beril Tutuncuoglu; Helene Foussard; Jyoti Batra; Kelsey Haas; Maya Modak; Minkyu Kim; Paige Haas; Benjamin J. Polacco; Hannes Braberg; Jacqueline M. Fabius; Manon Eckhardt; Margaret Soucheray; Melanie Brewer; Merve Cakir; Michael J. McGregor; Qiongyu Li; Zun Zar Chi Naing; Yuan Zhou; Shiming Peng; Ilsa T. Kirby; James E. Melnyk; John S Chorba; Kevin Lou; Shizhong A. Dai; Wenqi Shen; Ying Shi; Ziyang Zhang; Inigo Barrio-Hernandez; Danish Memon; Claudia Hernandez-Armenta; Christopher J.P. Mathy; Tina Perica; Kala B. Pilla; Sai J. Ganesan; Daniel J. Saltzberg; Rakesh Ramachandran; Xi Liu; Sara B. Rosenthal; Lorenzo Calviello; Srivats Venkataramanan; Yizhu Lin; Stephanie A. Wankowicz; Markus Bohn; Phillip P. Sharp; Raphael Trenker; Janet M. Young; Devin A. Cavero; Joseph Hiatt; Theo Roth; Ujjwal Rathore; Advait Subramanian; Julia Noack; Mathieu Hubert; Ferdinand Roesch; Thomas Vallet; Björn Meyer; Kris M. White; Lisa Miorin; Oren S. Rosenberg; Kliment A. Verba; David Agard; Melanie Ott; Michael Emerman; Davide Ruggero; Adolfo Garcí-Sastre; Natalia Jura; Mark von Zastrow; Jack Taunton; Olivier Schwartz; Marco Vignuzzi; Christophe d'Enfert; Shaeri Mukherjee; Matt Jacobson; Harmit S. Malik; Danica G Fujimori; Trey Ideker; Charles S Craik; Stephen Floor; James S. Fraser; John Gross; Andrej Sali; Tanja Kortemme; Pedro Beltrao; Kevan Shokat; Brian K. Shoichet; Nevan J. Krogan
Title: A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing Document date: 2020_3_22
ID: 38d6gb7o_15
Snippet: N targets stress granule protein G3BP1, an essential antiviral protein which is known to induce innate immune response through multiple mechanisms 52-54 . Common among coronaviridae is the manipulation of stress granules (SG) and related RNA biology, possibly leading to suppression of stress granules and host translation shutoff 55 . This functionality seems to benefit viral replication, as stress granules are inhibitory to replication of MERS-Co.....
Document: N targets stress granule protein G3BP1, an essential antiviral protein which is known to induce innate immune response through multiple mechanisms 52-54 . Common among coronaviridae is the manipulation of stress granules (SG) and related RNA biology, possibly leading to suppression of stress granules and host translation shutoff 55 . This functionality seems to benefit viral replication, as stress granules are inhibitory to replication of MERS-CoV 56 and other viruses 57 . The SARS-CoV-2 nucleocapsid (N) interactome includes many host mRNA binding proteins, including the SG related factors G3BP1/2, the mTOR translational repressors LARP1, and the protein kinases CK2 (Fig. 4a ). SGs are induced by protein kinase R (PKR)-mediated phosphorylation of eIF2α upon viral dsRNA recognition 57 . Promoting G3BP aggregation via the eIF4A inhibitor Zotatafin 58,59 or reducing SG disassembly by Silmitasertib inhibition of CK2 60 warrant investigation for treatment of SARS-CoV-2. The mTOR inhibitor rapamycin disrupts the binding of LARP1 to mTORC1 61 and has been shown to reduce MERS infection by ~60% in vitro 62 , another drug that could be tested for repurposing.
Search related documents:
Co phrase search for related documents- antiviral protein and host translation: 1, 2, 3, 4, 5, 6, 7, 8
- antiviral protein and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61
- antiviral protein and innate immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39
- antiviral protein and multiple mechanism: 1
- antiviral protein and RNA biology: 1, 2, 3
- antiviral protein and SARS nucleocapsid: 1, 2, 3, 4, 5, 6
- antiviral protein and SARS treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- antiviral protein and stress granule: 1
- antiviral protein and viral replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- antiviral protein and viral replication benefit: 1
- bind protein and host translation: 1
- bind protein and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- bind protein and innate immune response: 1, 2, 3, 4, 5, 6
- bind protein and mRNA bind protein: 1
- bind protein and mtor inhibitor: 1
- bind protein and mtor inhibitor rapamycin: 1
- bind protein and SARS nucleocapsid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- bind protein and SARS treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- bind protein and viral replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
Co phrase search for related documents, hyperlinks ordered by date